CCL2 and colorectal carcinoma: Furthermore, survival analysis using the Kaplan–Meier method and log-rank test demonstrated that high CCL2 expression was associated with shorter survival times in CRC patients (p = 0.048), identifying it as a potential risk factor for poor prognosis (Figure 2B).